Cleo Diagnostics
0
3
+$0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-4.06MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Cleo Diagnostics Ltd, a biotechnology company, engages in the development and patent of a blood test for the detection of ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.
Show More
CEO
Richard Allman
Country
Australia
ISIN
AU0000288045
Listings
0 Comments
Share your thoughts
FAQs
What is Cleo Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Cleo Diagnostics stocks are traded under the ticker CLDGF.
What is Cleo Diagnostics revenue for the last year?▼
Cleo Diagnostics revenue for the last year amounts to 0 USD.
What is Cleo Diagnostics net income for the last year?▼
CLDGF net income for the last year is -4.06M USD.
In which sector is Cleo Diagnostics located?▼
Cleo Diagnostics operates in the Health & Wellness sector.
When did Cleo Diagnostics complete a stock split?▼
Cleo Diagnostics has not had any recent stock splits.
Where is Cleo Diagnostics headquartered?▼
Cleo Diagnostics is headquartered in Melbourne, Australia.